MAT Programs - Medication-Assisted Treatment

Overview

Medication-Assisted Treatment combines FDA-approved medications such as buprenorphine (Suboxone), methadone, or naltrexone (Vivitrol) with counseling and behavioral therapies. MAT is clinically proven to reduce opioid use, prevent overdose deaths, decrease criminal activity, and improve treatment retention rates.

Who Is It For?

MAT is most effective for individuals with opioid use disorder (heroin, fentanyl, prescription painkillers) or alcohol use disorder. It stabilizes brain chemistry, blocks euphoric effects, and relieves cravings so the person can focus on recovery.

What Does It Include?

Comprehensive medical assessment

FDA-approved medications

Individual and group counseling

Regular drug screening

Psychiatric support

Care coordination

Peer support and recovery coaching

Ongoing monitoring and dosage adjustments

Frequently Asked Questions

What is medication-assisted treatment (mat)?

Medication-Assisted Treatment combines FDA-approved medications such as buprenorphine (Suboxone), methadone, or naltrexone (Vivitrol) with counseling and behavioral therapies. MAT is clinically proven to reduce opioid use, prevent overdose deaths, decrease criminal activity, and improve treatment retention rates.

Who should consider medication-assisted treatment (mat)?

MAT is most effective for individuals with opioid use disorder (heroin, fentanyl, prescription painkillers) or alcohol use disorder. It stabilizes brain chemistry, blocks euphoric effects, and relieves cravings so the person can focus on recovery.

How long does medication-assisted treatment (mat) last?

Typical duration is Ongoing (12+ months recommended). Length should be individualized based on clinical assessment and progress.

How much does medication-assisted treatment (mat) cost?

Average cost is $5,000 - $15,000/year. Required to be covered under ACA. Many facilities offer sliding-scale fees. Call (833) 546-3513 to verify coverage.

What is the success rate?

Success rates are approximately 60-75%. Success improves with longer treatment, aftercare, and addressing co-occurring disorders.